Antimicrobial peptides in the first line defence of human colon mucosa
暂无分享,去创建一个
[1] H. Lührs,et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways , 2003, Gut.
[2] S. C. Kim,et al. Endotoxin-Neutralizing Antimicrobial Proteins of the Human Placenta1 , 2002, The Journal of Immunology.
[3] Jesse D. Walters,et al. Discovery of five conserved β-defensin gene clusters using a computational search strategy , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Kagnoff,et al. Cell Differentiation Is a Key Determinant of Cathelicidin LL-37/Human Cationic Antimicrobial Protein 18 Expression by Human Colon Epithelium , 2002, Infection and Immunity.
[5] R. Bals,et al. Human β‐defensin 4: a novel inducible peptide with a specific salt‐sensitive spectrum of antimicrobial activity , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] O. Chertov,et al. Participation of mammalian defensins and cathelicidins in anti‐microbial immunity: receptors and activities of human defensins and cathelicidin (LL‐37) , 2001, Journal of leukocyte biology.
[7] J. Schröder,et al. Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic* , 2001, The Journal of Biological Chemistry.
[8] B. Christensson,et al. Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator , 2001, Nature Medicine.
[9] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[10] E. Hahn,et al. Secretion and tissue content of eosinophil cationic protein in Crohn's disease. , 2000, Journal of clinical gastroenterology.
[11] G. H. Gudmundsson,et al. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. , 1999, Journal of immunological methods.
[12] M. Kagnoff,et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. , 1999, Journal of immunology.
[13] Jun Yuan,et al. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. , 1999, Science.
[14] P. Nibbering,et al. Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages , 1999, Journal of leukocyte biology.
[15] Venge,et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[16] H. Jörnvall,et al. Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. , 1999, American journal of respiratory and critical care medicine.
[17] M. Ståhle-Bäckdahl,et al. The Human Cationic Antimicrobial Protein (hCAP18), a Peptide Antibiotic, Is Widely Expressed in Human Squamous Epithelia and Colocalizes with Interleukin-6 , 1999, Infection and Immunity.
[18] R I Lehrer,et al. Antimicrobial peptides in mammalian and insect host defence. , 1999, Current opinion in immunology.
[19] K. Bailey,et al. Potential Role of Epithelial Cell-Derived Histone H1 Proteins in Innate Antimicrobial Defense in the Human Gastrointestinal Tract , 1998, Infection and Immunity.
[20] R. Lehrer,et al. Secretory Phospholipase A2 Is the Principal Bactericide for Staphylococci and Other Gram-Positive Bacteria in Human Tears , 1998, Infection and Immunity.
[21] K. Berndt,et al. Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37* , 1998, The Journal of Biological Chemistry.
[22] M. Kagnoff,et al. Epithelial cells as sensors for microbial infection. , 1997, The Journal of clinical investigation.
[23] J. Schröder,et al. A peptide antibiotic from human skin , 1997, Nature.
[24] H. Wigzell,et al. The Expression of the Gene Coding for the Antibacterial Peptide LL-37 Is Induced in Human Keratinocytes during Inflammatory Disorders* , 1997, The Journal of Biological Chemistry.
[25] J. Odeberg,et al. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. , 1996, European journal of biochemistry.
[26] H. Jörnvall,et al. Biochemical and antibacterial analysis of human wound and blister fluid. , 1996, European journal of biochemistry.
[27] Domenico Romeo,et al. Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain , 1995, FEBS letters.
[28] M. Raida,et al. hBD‐1: a novel β‐defensin from human plasma , 1995 .
[29] A. Johnsen,et al. hCAP‐18, a cathelin/pro‐bactenecin‐like protein of human neutrophil specific granules , 1995, FEBS letters.
[30] R. Lehrer,et al. Bactericidal properties of murine intestinal phospholipase A2. , 1995, The Journal of clinical investigation.
[31] J. Odeberg,et al. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[32] Douglas E. Jones,et al. Defensin‐6 mRNA in human Paneth cells: implications for antimicrobia peptides in host defense of the human bowel , 1993, FEBS letters.
[33] Douglas E. Jones,et al. Paneth cells of the human small intestine express an antimicrobial peptide gene. , 1992, The Journal of biological chemistry.
[34] K. Kas,et al. Genomic structure and expression of the human fau gene: encoding the ribosomal protein S30 fused to a ubiquitin-like protein. , 1992, Biochemical and biophysical research communications.
[35] T. Ganz,et al. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. , 1989, Journal of immunology.
[36] D. Lipman,et al. Improved tools for biological sequence comparison. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[37] W. Beeken,et al. Phagocytes in cell suspensions of human colon mucosa. , 1987, Gut.
[38] P. Venge,et al. Mechanism of membrane damage mediated by human eosinophil cationic protein , 1986, Nature.
[39] H. Jörnvall,et al. Preparations of homeostatic thymus hormone consist predominantly of histones 2A and 2B and suggest additional histone functions. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[40] I. Olsson,et al. Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro , 1981, Parasite immunology.
[41] B. F. Miller,et al. ANTIBACTERIAL PROPERTIES OF PROTAMINE AND HISTONE. , 1942, Science.
[42] J. Johansson,et al. Antibacterial peptides in stimulated human granulocytes: characterization of ubiquitinated histone H1A. , 2002, European journal of biochemistry.
[43] P. Elsbach,et al. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. , 1996, The Journal of clinical investigation.
[44] H. G. Boman,et al. Peptide antibiotics and their role in innate immunity. , 1995, Annual review of immunology.
[45] R I Lehrer,et al. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. , 1993, Annual review of immunology.
[46] M. Schaechter,et al. Mechanisms of microbial disease , 1989 .
[47] H. Vogel,et al. Acetylornithinase of Escherichia coli: partial purification and some properties. , 1956, The Journal of biological chemistry.